IPCA Laboratories Limited - Company Snapshot & SWOT Analysis

June 2019 | 25 pages | ID: I82A2FD44F7EN
NAVADHI Market Research Pvt Ltd

Abstracts

Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949. The company is now a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. Ipca Laboratories is a therapy leader in India for anti-malarial with a market-share of over 34%.

In the 2013 the total revenue for IPCA Lab. Was INR 27.97 billion, which increased to INR 32.59 billion in 2018, registering growth rate of 3.10%.

In 2013 the revenue for IPCA Lab. Ltd. For India market was INR 10.81 billion, which increased to INR 16.95 billion in 2018, growing at a CAGR of 9.41%.

Scope of the IPCA Laboratories Limited - Company Snapshot & SWOT Analysis Report

• This report provides detailed information about IPCA Laboratories Limited including value chain analysis, financial performance, business strategy and SWOT analysis.
• The report identifies the growth drivers and inhibitors for global pharmaceutical market.
• This report provides information about current and future trends for global pharmaceutical market.

Contents

1. EXECUTIVE SUMMARY

Scope of the IPCA Laboratories Limited - Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 IPCA Laboratories Limited
  3.1.1 Company Profile
  3.1.2 IPCA Laboratories Limited in Pharmaceutical Manufacturing Value Chain
  3.1.3 IPCA Laboratories Limited: Financial Performance
  3.1.4 IPCA Laboratories Limited: Business Strategy
  3.1.5 SWOT Analysis of IPCA Laboratories Limited
    Strengths
    Weaknesses
    Opportunities
    Threats
  3.1.6 Key Customers of IPCA Laboratories Limited

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Orphan Drugs
Biologics and Biosimilars
Current Trends

1. INCREASING SEVERITY OF DRUG PRICE CONTROLS

2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS

3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS

4. INCREASING FOCUS ON CELL THERAPY

5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM

6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS

7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY

Notes
Company Information

List Of Exhibits

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Ipca Laboratories Limited
Exhibit 3.2 Contact details of Ipca Laboratories Limited
Exhibit 3.3 Laboratories Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 IPCA Laboratories Limited Revenue 2013-2018 (in INR billion)
Exhibit 3.5 Year-wise IPCA Laboratories Limited Revenue Growth 2014-2018 (in %)
Exhibit 3.6 Estimated Year wise IPCA Laboratories Limited Revenue 2013-2018 (in INR billion)
Exhibit 3.7 Estimated Year-wise IPCA Laboratories Limited Revenue Growth 2014-2018 (in %)
Exhibit 3.8 IPCA Laboratories Limited Revenue by Geography 2014 (in INR billion)
Exhibit 3.9 Year wise IPCA Lab Ltd. Export Sales Revenue Growth (in %)
Exhibit 3.10 Source wise Revenue share of IPCA Lab Ltd. (in %)
Exhibit 3.11 Source wise Revenue CAGR growth forecast for IPCA Lab. Ltd. 2019-23 (in %)
Exhibit 3.12 Forecast of IPCA Lab. Ltd. 2019-23 (in INR bn)
Exhibit 3.13 Forecast of India Market Revenue for IPCA Lab Ltd. 2019-23 (in INR bn)
Exhibit 3.14 Forecast of Export Market Revenue for IPCA Lab ltd. 2019-23 (in INR bn)
Exhibit 3.15 Key Products of IPCA Laboratories Limited
Exhibit 3.16 Key Services of IPCA Laboratories Limited
Exhibit 3.17 SWOT Analysis of IPCA Laboratories Limited
Exhibit 3.18 Key Customers of IPCA Laboratories Limited